Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study Versus Acetate
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158491 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Diana Rodríguez-Espinosa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, 08036 Barcelona, Spain. Hauptthemen laut MEDLINE: Hemodiafiltration, Magnesium, Acetates, Citric Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The choice of dialysate buffer in hemodialysis is crucial, with acetate being widely used despite complications. Citrate has emerged as an alternative because of its favorable effects, yet concerns persist about its impact on calcium and magnesium levels. This study investigates the influence of citrate dialysates (CDs) with and without additional magnesium supplementation on CKD-MBD biomarkers and assesses their ability to chelate divalent metals compared to acetate dialysates (ADs). A prospective crossover study was conducted in a single center, involving patients on thrice-weekly online hemodiafiltration (HDF). The following four dialysates were compared: two acetate-based and two citrate-based. Calcium, magnesium, iPTH, iron, selenium, cadmium, copper, zinc, BUN, albumin, creatinine, bicarbonate, and pH were monitored before and after each dialysis session. Seventy-two HDF sessions were performed on eighteen patients. The CDs showed stability in iPTH levels and reduced post-dialysis total calcium, with no significant increase in adverse events. Magnesium supplementation with CDs prevented hypomagnesemia. However, no significant differences among dialysates were observed in the chelation of other divalent metals. CDs, particularly with higher magnesium concentrations, offer promising benefits, including prevention of hypomagnesemia and stabilization of CKD-MBD parameters, suggesting citrate as a viable alternative to acetate. Further studies are warranted to elucidate long-term outcomes and optimize dialysate formulations. Until then, given our results, we recommend that when a CD is used, it should be used with a 0.75 mmol/L Mg concentration rather than a 0.5 mmol/L one.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
- Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
ORCID-Profile: Diana Rodríguez-Espinosa, Elena Cuadrado-Payán, Naira Rico, Mercè Torra, Gregori Casals, Francisco Maduell, José Jesús Broseta
Zitieren
APA
Rodríguez-Espinosa, D., Cuadrado-Payán, E., Rico, N., Torra, M., Fernández, R. M., Casals, G., Rodríguez-García, M., Maduell, F., & Broseta, J. J. (2024). Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study Versus Acetate. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158491
Vancouver
Rodríguez-Espinosa D, Cuadrado-Payán E, Rico N, Torra M, Fernández RM, Casals G, et al. Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study Versus Acetate. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158491
BibTeX
@article{RodrguezEspinosa2024,
author = {Rodríguez-Espinosa, Diana and Cuadrado-Payán, Elena and Rico, Naira and Torra, Mercè and Fernández, Rosa María and Casals, Gregori and Rodríguez-García, María and Maduell, Francisco and Broseta, José Jesús},
title = {Citrate Dialysate with and without Magnesium Supplementation in Hemodiafiltration: A Comparative Study Versus Acetate},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158491}
}
EUVIMED